findmyKOL
Clinical trialNCT05952934RecruitingPhase 2Interventional

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

SponsorUniversity of ArkansasEnrollment100Squamous Cell Carcinoma of Head and Neck
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Highlands Oncology Group, Pa

    Fayetteville, Arkansas, United States

    Joseph T Beck, MD, FACP
    Recruiting
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, United States

    Recruiting
  • Highlands Oncology Group, Pa

    Rogers, Arkansas, United States

    Joseph T Beck, MD, FACP
    Recruiting
  • Highlands Oncology Group, Pa

    Springdale, Arkansas, United States

    Joseph T Beck, MD, FACP
    Recruiting
  • Perlmutter Cancer Center at Nyu Langone Health

    Mineola, New York, United States

    Zujun Li, MD
    Recruiting
  • Perlmutter Cancer Center at Nyu Langone Health

    New York, New York, United States

    Zujun Li, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Feb 2024
Primary completion
31 Jul 2031
Completion
31 Jul 2031
Last update posted
8 Apr 2026
Registered enrollment
100
Registry id
NCT05952934

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.